Quinolones (Eye infection)
Drug Safety Update
See here for all drug safety updates relating to quinolones
Ciprofloxacin has a broad spectrum of activity and the eye drops are licensed for treatment of corneal ulcers. When treating ulcers intensive application is required throughout the day and night particularly for the first 2 days.
Ofloxacin also has a broad spectrum of activity and is effective against a wide range of organisms including Pseudomonas aeruginosa.
MTW Only: Moxifloxacin is approved as the first-line antibiotic drop for bacterial keratitis where a preservative-free formulation is required.
EKHUFT: Moxifloxacin is currently only approved for intraoperative antimicrobial prophylaxis in cataract surgery for patients with penicillin allergy - as per Royal College of Ophthalmologists guidelines.
| Pack |
|---|
| 5 ml |
For EKHUFT Initiation Only
| Pack |
|---|
| 5 ml |
Approved as the first-line antibiotic drop for bacterial keratitis where a preservative-free formulation is required.
| Pack |
|---|
| 5 ml |
- On Formulary Preferred
- On Formulary Second Line
- On Formulary Third Line
- Specialist Initiation
- Secondary Care Only
- Not Approved for Formulary